1. Stocks
  2. Xeris Biopharma Holdings Inc
  3. Swot
swot-logo

Xeris Biopharma Holdings Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Xeris Biopharma Holdings Inc has 30 Strengths, 3 Weaknesses, 2 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Relative Strength Index (RSI) Bullish

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

High Normalized Momentum Score

Consistent Highest Return Stocks over Five Years - Nifty500

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over Half Year (6 Months)

Relative Outperformance versus Industry over the Quarter (3 Months)

Relative Outperformance versus Industry over 1 Year

Stocks whose current price is 20% higher than week low, and more than previous close

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

New 52 week high today

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Overbought by Money Flow Index (MFI)

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Stock gained more than 20% in one month

Annual Net Profits improving for last 2 years

Top Gainers

Stock with Low PE (PE < = 10)

Stocks near 52 Week High with Significant Volumes

Biggest Price Gainers from Open

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month

Institutions decreased their shareholding last quarter

Promoters increasing shareholding QoQ